Skip to content

Bionano Genomics, Inc.

BNGO

CIK 0001411690

← back to feed
Revenue (TTM)
$27.24M
−7.4% YoY Q1 May 2026
Net Income (TTM)
−$26.77M
+76.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$5.49
+94.5% YoY Q1 May 2026
Gross Margin
47.9%
Q1 May 2026
Operating Margin
-120.0%
Q1 May 2026
Net Margin
-98.2%
Q1 May 2026
Free Cash Flow (TTM)
−$69.06M
Q1 May 2026
Cash
$3.43M
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
11.48M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings